Pharmaceutical composition with olive extract (hydroxytyrosol) and hop extract (xanthohumol) for intranasal application
A technology of olive extract and hydroxytyrosol, which is applied in the direction of drug combination, active ingredient of hydroxy compound, drug delivery, etc.
Inactive Publication Date: 2013-04-03
韦尔乌加医药学会
View PDF3 Cites 2 Cited by
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
[0008] Thus, the excessive release of aggressive ROS as an immune response to allergen
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View moreImage
Smart Image Click on the blue labels to locate them in the text.
Smart ImageViewing Examples
Examples
Experimental program
Comparison scheme
Effect test
example 1
[0087] Example 1 (composition)
[0088] water
example 2
[0089] Example 2 (composition)
[0090] water
example 3
[0091] Example 3 (composition)
[0092] water
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more PUM
Login to view more Abstract
The invention relates to a pharmaceutical composition containing hydroxytyrosol (olive extract) and xanthohumol (hop extract) as active substances for intranasal application, in particular in the form of a nasal spray for the prophylactic and/or curative treatment of colds.
Description
technical field [0001] The present invention relates to pharmaceutical compositions with antioxidants, especially for topical treatment of symptoms in case of viral, allergic and vasomotor rhinitis. The composition leads to freedom of nasal breathing due to swelling of the mucous membranes and a reduction in the production of secretions. Background technique [0002] Rhinitis is acute or chronic inflammation of the nasal mucosa, which can have various causes. [0003] In the case of viral rhinitis, the nasal mucosa reacts with the virus on the surface of the mucosa and triggers an immune response. Increased production of phlegm and fluid attempts to flush out the invader. Meanwhile, increased blood circulation - along with swelling of the mucous membranes - means calling in immune cells designed to render invading viruses harmless. Viral rhinitis can place severe stress on the immune system, severely weakening the body. Usually the virus damages the surface of the mucous...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more Application Information
Patent Timeline
Login to view more IPC IPC(8): A61K31/01A61K31/05A61K31/12A61K36/185A61K36/63A61K36/87A61K36/81A61P11/02A61P17/18A61P31/12
CPCA61K36/87A61K31/01A61K31/12A61K36/63A61K36/81A61K31/05A61K9/0043A61K36/185A61P11/02A61P17/18A61P31/12A61K2300/00A61K9/12
Inventor 克劳斯·埃伦贝格尔维尔纳·比贝尔舒尔特
Owner 韦尔乌加医药学会
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Try Eureka
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap